| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dca52c731f5284d36e33936016d3fe49 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 |
| filingDate |
2018-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abe457a213b40fbee553f2491b8c79a4 |
| publicationDate |
2019-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3434273-A1 |
| titleOfInvention |
Ceftriaxone for use in the treatment of dementia with lewy bodies |
| abstract |
Ceftriaxone is to be administrated to a subject suffered from dementia with Lewy bodies (DLB) to treat the DLB syndromes such as cognitive decline and neurological deficit in the subject thereof. Ceftriaxone can be parenterally or orally administrated to the subject in a dosage of 1.5-35 mg/kg/day. |
| priorityDate |
2017-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |